The success of a translational
integrated therapy against COVID-19
DOI: 10.13140/RG.2.2.15071.12964
Giuseppe R.Brera
Abstract
A sixty-year-old unvaccinated woman, a great smoker, with a determinate
temperament and basic trust, and a previous history of breast cancer with a
swab positive diagnosis of COVID-19 developed a
temperature of 40 degrees, with headache and cough, an indicator of a high
cytokine storm. She received an integrated therapy based on translational
medicine structured on well-studied natural molecules
integrated with Nimesulide and Doxiciclin. The woman recovered from the severe
COVID-19 syndrome in four days and joined the swab negativity in 10 days from
the beginning of symptoms returning to work on the 11th day.
Mass vaccination was the first time used to prevent a pandemic, but with
experimental mRNA and vectorial vaccines dangerous at the epigenetic-genetic
level,[1] [2] [3] [4] induced production of variants of concern evading immunity [5] and induced mass immunosuppression increasing vulnerability to
cancer, neurodegenerative disease, cardiovascular diseases, immune
thrombocytopenia, Bell's palsy, liver disease. These sera have been offered to
the market worldwide with unreliable clinical research methods, [6] produce a high risk of mortality for cardiovascular diseases under
39 yo people [7] and met in a minority of people, physicians, and investigators a
healthy diffidence and prudency to vaccinate people and themselves. The
epigenetic earthquake caused by mRNA vaccines, although an object of
controversy about its form,[8] found epidemiological and clinical evidence that confirm the
theoretical assumptions [9] [10] with many unpublished records. These sera should have requested
larger samples and an extended study over time. The fundamental epistemological
error at the origin of the SARS-COV 2 pandemic has been the lack of adoption in
public health of the paradigm change of medical science and medicine,
Person-Centered Medicine. This omission hampered an effective and cheap
alternative allowing people, primarily in countries with insufficient financial
resources, to prevent and care for viral and bacterial infections opening the
doors to an immense business for BIG-PHARMA increasing political powers, based
on illiteracy. To date, the obsolete and wrong deterministic-mechanistic
paradigm used to cope with the pandemic implementing only biotechnology and
profit is "Pathogen-infection- mortality risk" and not the right
indeterministic multidimensional one:" Pathogen-anti-pathogen allostasis =
antiviral metabolic allostasis and immunity stimulation -resilience-
recovery." [11] According to the Person-centered medicine primary prevention and therapy
paradigm, we are ethically, epistemologically, and scientifically obliged to
address preventive and clinical efforts to improve life quality and
psycho-biological resources to prevent and care for diseases and not to adopt
problem-centered epistemology, which enhances only the disease-centered stock
market only with a reductionist biotechnological approach. The World Health
Charter should be adopted worldwide. [12]
Antiviral drugs and monoclonal antibodies are developed through fragmented
research methods and show dangerous adverse effects, while there are in nature
pleiotropic, powerful and cheap molecules that, without adverse effects, act
contemporary at a biochemical and immunological level showing a great
preventive action and effective therapy. The road map for prevention and
treatment should be based on the physiology revolution of
"allostasis" (Sterling and Heyer), to date unknown to most physicians
and investigators. [13] Substituting the obsolete concept of "Homeostasis" (Cannon).
The antiviral targets of prevention and a successful therapy anti-SARS-COV
two variants of concern (VOC) should be addressed to use pleiotropic molecules
to increase resilience to the infection blocking it (Table 1).
One of us recently introduced the COVID-19 person-centered prevention and
early treatment paradigm based on the epistemological concept of antiviral
allostasis and immunostimulation, identifying the relativity of the SARS-COV 2
entry into cells and reviewing the pleiotropic antiviral targets of naturals
molecules spread worldwide. .[14] [15], a strategy inspired by Person-Centered Medicine (PCM), the current
paradigm of Medical Science, not well known yet. [16] At
the clinical level, PCM acts through the Person-Centered Clinical Method that
allows the physician to identify the subjective-biological-environmental patient's
resources for improving the person's lifestyle quality. [17]
In fact, a clinical case is not a probabilistic event of a natural law
mechanistic and deterministic alterations [18] not to be
considered independent of the person's possibilities for the best personal
being. This approach is founded on the person-centered concept of health
as" The choice of the best possibilities for being the best human
person" [1] related to the interaction among the spiritual- psycho-neuro-endocrine,
immunity systems, [19] determining the allostatic changes of the individual epigenetic
transmission. The COVID-19 prevention and early treatment inducing an antiviral
allostasis and immunostimulation is entrusted to the person's natural immune
system through the metabolic antiviral allostatic changes and can be reinforced
by a resource-centered healthy lifestyle and powerful antiviral substances that
act as pleiotropic natural epigenetic programmers at immunity -biochemical
level. Nutrition quality and its possibility is part of healthy or bad life
quality and education to health, which cannot be separated by the ontologic
human freedom to interpret experience and choose among experience possibilities
and build reality., making health relative to the individual interpretation
quality of experience possibilities.[20]
Curcumin, Aloe, Lactoferrin, Epigallocatechin, Beta-glucans Sphingosine,
Lysozyme, Mannan binding lectins, and Quercetin are natural molecules with a
well-documented powerful pleiotropic antiviral allostasis and immunostimulant
actions. [21] Vit A and C are immunostimulants, and VIT D metabolites,
cathelicidin, have direct virucide properties. [22] Lysozyme
has a barrier effect in viral infections, is an immunostimulant but suppresses
TNF-α and IL-6 production by macrophages.and hydrolyzes gram-positive bacterial
walls. [23]Nimesulide has potent anti-inflammatory and antiviral properties, with
well-studied significant therapeutic successes [24], and its association with maltodextrins also results in immunostimulation.
[25] [26] Doxiciclin also has antibacterial and antiviral properties. [27] Conversely, the antipyretic paracetamol suggested and defended by the
Italian Health Ministry to treat early COVID is dangerous because it promotes
coagulation and has no anti-inflammatory effects, and this illiterate health
policy was responsible for thousands of deaths. [28]
A sixty years old unvaccinated woman, a great smoker, with a determinate
temperament, good basic trust, and a previous history of breast cancer with a
positive swab diagnosis of COVID-19 developed a temperature of 40 degrees, with
headache and cough, an indicator of a high cytokine storm. Paracetamol
administration, prescribed by phone by an illiterate emergency unit, according
to the correspondent Italian health ministry indications, was suspended. An
integrated pleiotropic therapy with drugs was prescribed with the resolution of
COVID-19 syndrome in four days and the swab negativity in 10 days. The woman
started to work on the 11th day of the pleiotropic therapy. (Table 2)
A pleiotropic person-centered oriented therapy is more effective than a
fragmentized molecular one built on the imperant obsolete and wrong mechanistic
paradigm of medical science. Many cheap natural and synthesis pleiotropic
molecules offer the opportunity for effective prevention and therapy (Table 2)
and allow joining at the same time, the anti-SARS-COV 2 targets extended to
other communicable,-like influenza virus- and non-communicable diseases, like
cancer, which shares with the first infection phase allostatic homologies. At
the prevention level, the effectiveness of a pleiotropic activity of natural
substances confers more protection than experimental mRNA vaccines that, after
120 days, are waning and in a paradoxical way, increase the risk of infections
in vaccinated people confirming the epigenetic-induced immunosuppressive
action,[29] and the absence of the B-cell memory.
Moreover, mRNA experimental vaccines show dangerousness caused by genotoxic
and immunosuppressive effects, based on the silencing of microRNA and DNA gene
promoters, through methylation and vectorial vaccines hybridizing DNA resulting
in a vulnerability to autoimmunity. mRNA vaccines produce only
circulating IGG and less IGA, waning in a short time, are inactive against VOC,
and do not generate Memory B cells in lungs[30] with a high
rate of life-threatening adverse effects. Cells' methylation induces an
increased risk of cancer. [31] [32] In vaccinated oncologic patients, there is an increase in
infections, admissions to hospitals, and deaths. [33] [34]Monoclonal antibodies and antiviral drugs have many serious adverse
effects, only induce fragmented therapeutical actions, and are expensive, while
pleiotropic prevention and therapy join different antiviral targets
simultaneously. (Table 1). The availability of pleiotropic natural substances
worldwide and their low costs offer great possibilities for SARS-COV prevention
and therapy in developing countries. Moreover, there is the impossibility of
vaccinating the entire world. Antiviral allostasis and preventive
immuno-stimulation, the pleiotropic strategy in therapy open new possibilities
for self-care and health education by adopting the new paradigm of
person-centered prevention, an alternative to future mass vaccination
strategies with experimental vaccines, and a profit-centered stock market of
disease.
Clinical Reports of the Milan School of
Medicine. 2022; 1
Table 1
Pleiotropic targets against SARS-COV 2 and
variants of concern
1.
Inhibition
of the virus binding to receptors (barrier effect);
2.
change
of the Receptor Binding Domain
3.
inhibition
of proteases cleaving the virus and
blocking its entry into the cell
4.
prevention
of NK and CD8 inhibition
5.
Increase
of cytotoxic function of NK and LAK
6.
Immunostimulation
7.
inactivation
by viruses of the P53 gene and its reactivation;
8.
inhibition
of replication
9.
prevention
of the critical anergy after the seventh
day of the disease shared by patients with atherosclerosis -based
comorbidities;
10.
creation
and or induction of natural and or (A) humoral adaptive immunity(B)
11.
prevention
and inhibition of the virus induced viral allostatic metabolism and activation
of antiviral allostasis
12.
prevention
of cytokine storm-induced lung inflammation and in oral, nasal mucosae, and
upper respiratory ways;
13.
plasma alkalinization
14.
Epigenetic programming (demethylation)
15.
Virus
opsonization
©Giuseppe
R.Brera 2022
Clinical Reports of
the Milan School of Medicine. 2022; 1
Table 2 Posology in the
clinical case treatment
Substance-molecule
|
Posology
|
Pleiotropic
action of nutraceutics
(table 1)
|
Curcumin
|
Curcumin
500 mg x2
5’Inhalation
of turmeric powder (10 g- two teaspoons)
vapors
from a solution with 100 ml of water at a boiled temperature
|
1,2,4,7,8,9,11,12,14
|
Aloe
extract
|
50
ml x 2
|
1,3,6,11
|
Lactoferrin
|
200
mg x 2 before meals
|
1,4,5,6,8,10
|
Epigallocatechin
|
Infusion
of green tea (40°) four glasses per
day ( 800 ml )
|
1,3,6.8,9.11,14
|
Resveratrol
|
1000
mg x 2 before meals
|
1,6,8,9,11,12,14
|
Sphingosine
Beta-
Glucans
Lactobacilli
|
Kefir
milk 200 ml x 3
|
SPH
1,12
BG 10
LB 6,12
|
Melatonin
|
5
mg before sleeping
|
6,9,11,12
|
Vit
D
|
10.000
U ( 7 days) after 1000
|
1,2,9,11,12,14
|
Vit,
C
|
500
mg
|
6,9,11,12,14
|
Vit
A
|
5000
U
|
4,6,9,10,11,12,14
|
Nimesulide
and maltodextrins
|
400
mg x 2
|
1,6
,9,12
|
Doxiciclin
|
100
mg x1 (first dose 200 mg)
|
3.14
and antipoptois
|
Quercetin
(foods)
|
Foods
rich of quercetin
|
1,3,6,8,11,12,14
|
Mannan
binding lectins
|
Foods rich of MBL
|
1,2,3,7,9,12,15
|
|
Table
1 Posology of the integrated
pleiotropic therapy-
( Doses are
referred one-two time a day , morning ad evening)
|
©Giuseppe R.Brera 2022
[1] Lockhart J et al. Nucleotide Modification Alters
MicroRNA-Dependent Silencing of MicroRNA Switches. Mol Ther Nucleic Acids.
2019;14:339-350. doi:10.1016/j.omtn.2018.12.00
[2] Doerfler W. Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based
Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral
Genes Expressed in Vector-based Vaccines? Virus Res. 2021 Sep;302:198466. doi:
10.1016/j.virusres.2021.198466. Epub 2021 June 1. PMID: 34087261; PMCID:
PMC8168329.
[3] Seneff, S. et al. Innate immune suppression by SARS-CoV-2
mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs. Food
and chemical toxicology 2022; 164, 113008. Internet:https://doi.org/10.1016/j.fct.2022.113008
[4] Brera G.R. Scientific evidence of mRNA and vectorial vaccines
genotoxicity inducing tumors and psycho-neuro-behavioral disorders. Scientific
Report of the Milan School of Medicine; December 7, 2021, DOI:
10.13140/RG.2.2.29151.18081
[5] Aleem A, Akbar Samad AB, Slenker AK. Emerging Variants of
SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). 2022 Oct 10.
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022
Jan–. PMID: 34033342
[6] Cotton C. Evaluation des pratiques méthodologiques mises en
œuvre dans les essais Pfizer dans le développement de son vaccin ARN-messager
contre la COVID-19 en regard des Bonnes Pratiques Cliniques Présentation OPECTS
05/04/2022 – internet https://christine-cotton.1ere-page.fr/evaluation-essais-pfizer/ Access 10/05)2022
[7] Florida state (USA) Exploring the relationship between
all-cause and cardiac-related mortality following COVID-19 vaccination or
infection in Florida residents: a self-controlled case series study. Internet https://floridahealthcovid19.gov/wp-content/uploads/2022/10/20221007-guidance-mrna-covid19-va Access October 8, 2022
[8] Barriere, J. et al. . Reply to “Innate immune suppression by
SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and
MicroRNAs. Important concerns on the validity of this article. ”: OSF preprint
May 10 2022 https://doi.org/10.31219/osf.io/m58yh
[9] Sekizawa A et al. Rapid progression of marginal zone B-cell
lymphoma after COVID-19 vaccination (BNT162b2): A case report. Front Med
(Lausanne). 2022 Aug 1;9:963393. doi: 10.3389/fmed.2022.963393. PMID: 35979213;
PMCID: PMC9377515.
[10] Goldman S et. al. Rapid Progression of Angioimmunoblastic T
Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report.
Front Med (Lausanne). 2021 Nov 25;8:798095. doi: 10.3389/fmed.2021.798095.
PMID: 34901098; PMCID: PMC8656165.
[11] Brera, G.R. Person-Centered Medicine and Person Centered Clinical
Method. Milano:
Università Ambrosiana ed.: 2021 ISBN: 9798726465432
[12]
Università Ambrosiana. “ Medical Science and health Paradigm Change” G.R.
Brera ed.. Proceedings of the Conference Milan 13-14-15 October 2017. Milan;
Università Ambrosiana: 2018 Internet www.health paradigm change.it
[13] Sterling P., Eyer J. Allostasis: a new paradigm to explain arousal
pathology. In: Fischer S Reason J. editors. Handbook of Life Sciences,
cognition, and Hea[7] Robinson, E.G., Fernald R., Clayton D. Genes and Social
Behavior.Science 2008;322:896-lth. New York 1988: J.Wiley and sons;p. 629-649
[14] Brera G.R. SARS-COV 2 allostasis and the people and person-centered
prevention. A new prevention strategy based on people's metabolic and immune
shield for the pandemic shutdown. Part 1 The Sars-Cov 2 entry and COVID-19.
Milan. Università Ambrosiana , 2021. ISBN: 9798530093906
[15] Brera G.R. SARS-COV 2- allostasis and the people and person-centered
prevention. Part 2 The Sars-Cov 2- induced immunosuppression and covid-19
anergy. Part 3 The antiviral metabolic allostasis and preventive
immunostimulation -How to induce zero risk for covid-19. Milan: Ambrosiana
University: 2021. ISBN: 9798547583520
[16] Brera G. R, The manifesto of Person-Centred Medicine. Medicine, Mind
and Adolescence 1999.XIV, 1-2:7-11
[17] Brera, G.R. Person-Centered Medicine and Person Centered Clinical
Method. Milano: Università Ambrosiana ed.: 2021 ISBN: 9798726465432
[18] Gadamer H.G. Where health is hidden. Frankfurt; Suhrkamp Verlag, 1993
(German)
[19] Lissoni P. The spirit marries the science. Calco, Ripamonti , 2008
(Italian)
[20] Brera GR "The Person-centered Health relativity" and the
"People and Person-Centered Prevention theories." From epistemology
to the COVID-19 pandemic shut-down. Research Gate. DOI:
10.13140/RG.2.2.26720.40960
[21] Qingqing Dai et al) Modulation of Human Neutrophil Peptides on P.
aeruginosa Killing, Epithelial Cell Inflammation and Mesenchymal
Stromal Cell Secretome Profiles. Journal of Inflammation Research. 2019;
12: 335-343
[22] Mitra S et al. Exploring the Immune-Boosting Functions of Vitamins
and Minerals as Nutritional Food Bioactive Compounds: A Comprehensive Review.
Molecules. 2022 Jan 16;27(2):555. DOI: 10.3390/molecules27020555. PMID:
35056870; PMCID: PMC8779769.
[23] Mann JK, Ndung'u T. The potential of lactoferrin,
ovotransferrin and lysozyme as antiviral and immune-modulating agents in
COVID-19. Future Virol. 2020 Sep:10.2217/fvl-2020-0170. doi:
10.2217/fvl-2020-0170. Epub 2020 Oct 8. PMCID: PMC7543043.
[24] Suter F et al. A simple, home-therapy algorithm to prevent
hospitalization for COVID-19 patients: A retrospective observational
matched-cohort study. clinical medicine. 2021 Jul;37:100941. DOI:
10.1016/j.eclinm.2021.100941. Epub 2021 June 9. PMID: 34127959; PMCID:
PMC8189543. (Medrix 25/03/2021
[25] Gozzi-Silva SC
et al. Immunomodulatory Role of Nutrients: How Can Pulmonary Dysfunctions Improve?
Front Nutr. 2021 September 7;8:674258. doi: 10.3389/fnut.2021.674258. PMID:
34557509; PMCID: PMC8453008.
[26] Martin TR et al. Innate immunity in the lungs. Proc Am Thorac Soc.
2005;2(5):403-11. DOI: 10.1513/pats.200508-090JS. PMID: 16322590; PMCID:
PMC2713330.
[27] Dorobisz K et al.. Doxycycline in the Coronavirus Disease 2019
Therapy. Ther Clin Risk Manag. 2021 Sep 21;17:1023-1026. doi:
10.2147/TCRM.S314923. PMID: 34584416; PMCID: PMC8464303.
[28] Pandolfi S et al. Paracetamol in the home treatment of early
COVID-19 symptoms: A possible foe rather than a friend for elderly patients? J
Med Virol. 2021 Oct;93(10):5704-5706. doi: 10.1002/jmv.27158. Epub 2021 June
30. Erratum in: J Med Virol. 2022 Mar;94(3):1246. PMID: 34170556; PMCID: PMC8426871.
[29] Nordström P et al. Risk of infection, hospitalisation, and death up
to 9 months after a second dose of COVID-19 vaccine: a retrospective, total
population cohort study in Sweden. Lancet. 2022 Feb 26;399(10327):814-823. doi:
10.1016/S0140-6736(22)00089-7. Epub 2022 Feb 4. PMID: 35131043; PMCID:
PMC8816388.
[30] Federico M. Biological and Immune Responses to Current
Anti-SARS-CoV-2 mRNA Vaccines beyond Anti-Spike Antibody Production. Journal of Immunology Research.
2022. DOI https://doi.org/10.1155/2022/4028577
[31] Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27-56. doi:
10.1016/B978-0-12-380866-0.60002-2. PMID: 20920744.
26 Peng Y et al.The role of MicroRNAs in human cancer. Signal
Transduct Target Ther. 2016 Jan 28;1:15004. doi: 10.1038/sigtrans.2015.4. PMID: 29263891; PMCID: PMC5661652.
27 Wang W et al. Breakthrough SARS-CoV-2 Infections,
Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US
Between December 2020 and November 2021. JAMA Oncol. 2022 Apr 8. doi:
10.1001/jamaoncol.2022.1096. Epub ahead of print. PMID: 35394485
|